More: HIV Management 2008: The New York Course

NY Course 2008: Perspectives and Controversies CME

April 24 - 25, 2008, New York, NY

Author Information and Disclosures

This activity was developed in collaboration with HIV Management 2008: The New York Course.

HIV Management 2008: The New York Course is an online educational collaboration between Albert Einstein College of Medicine and Medscape

Release Date: May 30, 2008; Valid for credit through May 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. The Past as Prologue -- An Expert PerspectiveJohn G. Bartlett, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
  2. Controversies in HIV ManagementMartin S. Hirsch, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
Downloadable Slides
The Past as Prologue -- An Expert Perspective
Downloadable PowerPoint Slides by John G. Bartlett, MD
Controversies in HIV Management
Downloadable PowerPoint Slides by Martin S. Hirsch, MD

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and were developed in collaboration with the HIV Management 2008: The New York Course.

Copyright © 2008 Medscape.
Merck, BMS
Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Consider the evolution of the principles of antiretroviral therapy
  2. Discuss how the newer classes of agents and individual drugs may further enhance treatment response
  3. Consider how new classes of drugs and individual agents may be best utilized to refine antiretroviral therapy at the present time
  4. Understand the issues surrounding decisions on when to initiate antiretroviral therapy, and with what, in established HIV infection
  5. Appreciate the role, or lack thereof, of treatment of concomitant herpes simplex virus infections in the prevention of transmission of HIV
Authors and Disclosures

John G. Bartlett, MD
Disclosure: John G. Bartlett, MD, has disclosed that he has served as a consultant to Abbott, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Tibotec, Johnson & Johnson, and Arpida. Dr. Bartlett has also disclosed that he has received grants and/or research support from Gilead.


Martin S. Hirsch, MD
Disclosure: Martin S. Hirsch, MD, has disclosed that he has served as a consultant to Merck.
 
Albert Einstein College of Medicine
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

All other healthcare professionals completing continuing education credit for this activity will be issued a certificate of participation.

Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.